Literature DB >> 21832916

How to diagnose and manage difficult problems of calcium metabolism in sarcoidosis: an evidence-based review.

Violeta Vucinic1, Vesna Skodric-Trifunovic, Svetlana Ignjatović.   

Abstract

PURPOSE OF REVIEW: Calcium metabolism impairments have long been recognized as a complication of sarcoidosis. For more than six decades physicians and investigators have been trying to elucidate this severe problem; nevertheless it seems puzzlingly new for both readers and researchers. RECENT
FINDINGS: This review highlights the problems of calcium metabolism in sarcoidosis in relation to vitamin D synthesis, which is definitely altered by granulomatous inflammation. Increasing evidence suggests that vitamin D is an immunomodulating hormone that inhibits both antigen presentation by cells of the innate immune system, and the cytokine release and proliferation of Th1 cells. As calcium homeostasis is primary controlled by levels of vitamin D, parathyroid hormone (PTH) and calcitonin, this literature review emphasizes the role of general immunomodulating properties of vitamin D and the correlation with calcium metabolism impairments, with the special accent on already known interactions with sarcoidosis.
SUMMARY: Granuloma formation has been related to a failure of the innate immune system. One of the possible explanations is a vitamin D deficiency. The evidence-based findings on calcium metabolism impairments and the interactions with vitamin D might help both clinicians and researchers in developing new strategies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21832916     DOI: 10.1097/MCP.0b013e328348b3cb

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  3 in total

1.  Hypergammaglobulinemia, normal serum albumin and hypercalcaemia: a case of systemic sarcoidosis with initial diagnostic confusion.

Authors:  Sathiji Nageshwaran; Kalpita Majumdar; Sabina Russell
Journal:  BMJ Case Rep       Date:  2012-06-21

2.  Repository corticotropin injection (H.P. Acthar gel) for the treatment of sarcoidosis-induced hypercalciuria and vitamin D dysregulation: a pilot, open label study.

Authors:  Marc A Judson; Aakash Modi; Furqan Ilyas; Recai Yucel
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  Long-term hypervitaminosis D-induced hypercalcaemia treated with glucocorticoids and bisphosphonates.

Authors:  Chase C Houghton; Susie Q Lew
Journal:  BMJ Case Rep       Date:  2020-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.